BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23708152)

  • 1. A formulated red ginseng extract upregulates CHOP and increases TRAIL-mediated cytotoxicity in human hepatocellular carcinoma cells.
    Lee YS; Lee DG; Lee JY; Kim TR; Hong SS; Kwon SW; Kim YS
    Int J Oncol; 2013 Aug; 43(2):591-9. PubMed ID: 23708152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.
    Lee JY; Jung KH; Morgan MJ; Kang YR; Lee HS; Koo GB; Hong SS; Kwon SW; Kim YS
    Mol Cancer Ther; 2013 Mar; 12(3):274-85. PubMed ID: 23053497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF; Cao JG; Tian L; Liu F
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeic acid phenethyl ester enhances TRAIL-mediated apoptosis via CHOP-induced death receptor 5 upregulation in hepatocarcinoma Hep3B cells.
    Dilshara MG; Jayasooriya RG; Park SR; Choi YH; Choi IW; Kim GY
    Mol Cell Biochem; 2016 Jul; 418(1-2):13-20. PubMed ID: 27260301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoobtusilactone A sensitizes human hepatoma Hep G2 cells to TRAIL-induced apoptosis via ROS and CHOP-mediated up-regulation of DR5.
    Chen CY; Yiin SJ; Hsu JL; Wang WC; Lin SC; Chern CL
    J Agric Food Chem; 2012 Apr; 60(13):3533-9. PubMed ID: 22400995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells.
    Jung KJ; Min KJ; Bae JH; Kwon TK
    Oncotarget; 2015 Jan; 6(3):1556-68. PubMed ID: 25596735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.
    Moon DO; Asami Y; Long H; Jang JH; Bae EY; Kim BY; Choi YH; Kang CH; Ahn JS; Kim GY
    Toxicol In Vitro; 2013 Feb; 27(1):257-63. PubMed ID: 22982206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
    Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation.
    Mota A; Jiménez-Garcia L; Herránz S; de Las Heras B; Hortelano S
    Toxicol Appl Pharmacol; 2015 Aug; 286(3):168-77. PubMed ID: 25930665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins.
    Subramaniam A; Loo SY; Rajendran P; Manu KA; Perumal E; Li F; Shanmugam MK; Siveen KS; Park JI; Ahn KS; Hui KM; Kumar AP; Sethi G
    Apoptosis; 2013 Oct; 18(10):1175-87. PubMed ID: 23700228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Lee TJ; Um HJ; Min do S; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2009 Jun; 46(12):1639-49. PubMed ID: 19345731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROS-dependent ER-stress.
    Moon DO; Park SY; Choi YH; Ahn JS; Kim GY
    Biochem Pharmacol; 2011 Dec; 82(11):1641-50. PubMed ID: 21903093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells.
    Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T
    Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.
    Pellerito O; Calvaruso G; Portanova P; De Blasio A; Santulli A; Vento R; Tesoriere G; Giuliano M
    Mol Pharmacol; 2010 May; 77(5):854-63. PubMed ID: 20159939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation.
    Jung EM; Park JW; Choi KS; Park JW; Lee HI; Lee KS; Kwon TK
    Carcinogenesis; 2006 Oct; 27(10):2008-17. PubMed ID: 16613838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis.
    Koyama M; Sowa Y; Horinaka M; Goda AE; Fujiwara J; Sakai T
    Oncol Rep; 2014 Feb; 31(2):947-54. PubMed ID: 24276615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage.
    Jin CY; Park C; Moon SK; Kim GY; Kwon TK; Lee SJ; Kim WJ; Choi YH
    Anticancer Drugs; 2009 Sep; 20(8):713-22. PubMed ID: 19617819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].
    Zhu RX; Lin JS; Song YH; Li PY; Tao LW
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):261-4. PubMed ID: 16875623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
    Jayasooriya RG; Choi YH; Hyun JW; Kim GY
    Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.